[1]
N. Akbar, “Efficacy and Safety of In-Asia-manufactured Interferon alpha-2b in Combination with Ribavirin for Therapy of Naïve Chronic Hepatitis C Patients: A Multicenter, Prospective, Open-Label Trial”, InaJGHE, vol. 10, no. 1, pp. 7–13, Jan. 2009.